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Rapid Evolution of NK Cell Receptor Systems
Demonstrated by Comparison
of Chimpanzees and Humans
receptor complex (LRC) on human chromosome 19
(Baker et al., 1995; Wagtmann et al., 1997). Although
serving apparently similar functions, the MHC class I
receptors of the NKC and LRC have very different struc-
tures. The extracellular part of an NKC-encoded recep-
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a C-type lectin (Boyington et al., 1999), whereas that ofImmunology
an LRC-encoded receptor is made up of immunoglobu-Stanford University
lin-like domains (Fan et al., 1997).Stanford, California 94305
Comparison of the MHC class I receptors of mouse²Department of Immunology
and human NK cells revealed unexpected differences.DNAX Research Institute for Molecular and Cellular
Receptors for classical MHC class I molecules of miceBiology
(H-2K,D,L) are lectin-like Ly49 molecules encoded by aPalo Alto, California 94306
multigene family within the NKC (Yokoyama et al., 1990).
Intensive search revealed only one human Ly49 gene
and it is nonfunctional (Westgaard et al., 1998; BartenSummary
and Trowsdale, 1999). NK cell receptors for classical
MHC class I molecules of humans (HLA-A,B,C) are theThat NK cell receptors engage fast-evolving MHC
killer cell immunoglobulin-like receptors (KIR) encodedclass I ligands suggests that they, too, evolve rapidly.
by a multigene family in the LRC (Martin et al., 2000;To test this hypothesis, the structure and class I speci-
Wilson et al., 2000). No mouse homolog of a KIR geneficity of chimpanzee KIR and CD94:NKG2 receptors
has been found. Beside the differences in Ly49 and KIR,were determined and compared to their human coun-
mice and humans do share an MHC class I receptor.terparts. The KIR families are divergent, with only three
This lectin-like receptor comprises heterodimers ofKIR conserved between chimpanzees and humans.
CD94 with either NKG2A or NKG2C, all three polypep-By contrast, CD94:NKG2 receptors are conserved.
tides being encoded by NKC genes (Phillips et al., 1996;Whereas receptors for polymorphic class I are diver-
Vance et al., 1998). The ligands for these receptors aregent, those for nonpolymorphic class I are conserved.
nonclassical MHC class I molecules: HLA-E in humansAlthough chimpanzee and human NK cells exhibit
(Borrego et al., 1998; Braud et al., 1998; Lee et al., 1998)identical receptor specificities for MHC-C, they are
and Qa-1b in mice (Vance et al., 1998).mediated by nonorthologous KIR. These results dem-
Apparent from the comparison of mouse and humanonstrate the rapid evolution of NK cell receptor sys-
NK cell receptors is that NKC-encoded receptors Ly49,tems and imply that ªcatching upº with class I is not
CD94, and NKG2 existed before the separation of thethe only force driving this evolution.
rodent and primate lineages z100 million years ago (Ku-
mar and Hedges, 1998). Since that time both lineagesIntroduction
have maintained functional CD94:NKG2 receptors. How-
ever, although functional Ly49 genes have been main-Natural killer (NK) cells are essential elements in the
tained by rodents, they were extinguished on the evolu-early response to infection, particularly viral infections
tionary path that led to modern humans. Conversely,(Biron et al., 1999). The effector functions of NK cellsÐ
the presence of KIR genes in primates but not rodentscytotoxicity and cytokine secretionÐare in part con-
implies that KIR genes evolved subsequent to separa-trolled by inhibitory cell surface receptors that engage
tion of the two lineages and that in humans they have
MHC class I (reviewed in Lanier, 1998). This mechanism
now taken on the functions performed by Ly49 in mice.
prevents NK cells from attacking healthy autologous
Previously, we proposed that the differences in human
cells and directs them to kill cells with impaired expres-
and mouse NK cell receptors are long-term conse-
sion of MHC class I, as can occur during viral infection
quences of the rapid evolution of classical MHC class
and progressive tumor growth. Because NK cells are I genes; a process driven by the idiosyncratic pressures
sensitive to loss-of-self MHC class I, they are said to of pathogens upon host immunity, particularly cytotoxic
recognize ªmissing selfº (Ljunggren and Karre, 1990). T cells (Gumperz and Parham, 1995). We envisaged that
The inhibitory MHC class I receptors of NK cells are a fraction of the MHC class I variants selected for novel
encoded by two gene complexes on different chromo- patterns of antigen presentation to T cells have reduced
somes: the natural killer complex (NKC) on mouse chro- capacity to engage NK cell receptors. Such innovation in
mosome 6 (reviewed in Brown et al., 2000) and human MHC class I would in turn impose pressure upon NK cell
chromosome 12 (Renedo et al., 1997), and the leukocyte receptors for changes that sustain existing interactions
with MHC class I ligands or create new ones. That mouse
³ To whom correspondence should be addressed (e-mail: peropa@- H-2D,K,L allotypes lack the determinants recognized by
leland.stanford.edu).
KIR, and that human HLA-A,B,C allotypes lack the determi-§ These authors contributed equally to this work.
nants recognized by Ly49, can be seen as a result of thisk Present address: University of California San Francisco, Depart-
coevolutionary process (Valiante et al., 1997a).ment of Microbiology and Immunology, San Francisco, California
94143. A prediction of the model is that genes encoding NK
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Figure 1. Common Chimpanzees Have Diverse KIR Genotypes
Genomic DNA from 48 unrelated common chimpanzees was typed by PCR-SSP for 10 Pt-KIR. Shown in (A) is a representative agarose gel
electrophoresis of PCR products obtained from typing eight chimpanzees for the indicated KIR. Sequence analysis of PCR bands from these
individuals demonstrated the fidelity of the typing assay. A summary of the typing of 48 chimpanzees is shown in (B). A shaded box indicates
the presence of a KIR; an unshaded box indicates its absence.
cell receptors with specificity for classical MHC class I class I. Furthermore, autologous chimpanzee B cell lines
are resistant to lysis by NK cells (Clark and Sturge, 1981),can evolve rapidly to follow the evolution of their ligands.
Testing this prediction requires comparison of species suggesting the presence of inhibitory receptors for MHC
class I, and Southern blots indicate the presence of ain which the NK cell receptors and MHC class I ligands
are far less disparate than those of mice and humans. chimpanzee KIR gene family (Valiante et al., 1997a).
Here we report on an investigation of the structure,For this purpose, comparison of human and common
chimpanzee has considerable advantage. They are function, and expression of chimpanzee NK cell recep-
tors. Comparison of the chimpanzee receptors with theirclosely related species that diverged from a common
ancestor z5 million years ago (Horai et al., 1995) and human counterparts reveals the considerable extent to
which z5 million years of independent evolution andnow retain an estimated 98.4% sequence similarity in
their genomes (Sibley et al., 1990). Of particular rele- differential exposure to pathogens can diversify NK cell
receptor systems.vance to our purpose, chimpanzees have orthologous
MHC class I genes, of which MHC-A, B, and C are highly
polymorphic in both species and have diverged to where Results
no alleles are shared (Cooper et al., 1998). However, the
class I genes have not diverged to the point of fixation Three KIR Lineages Are Differentially Conserved
in Chimpanzee and Humanof species-specific characteristics, and the sequence
motifs that define human MHC class I interaction with Complementary DNA clones encoding chimpanzee KIR
were isolated from peripheral blood or cultured NK cellsKIR and CD94:NKG2 are present in chimpanzee MHC
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Figure 2. Most Chimpanzee KIR Are Structurally Divergent from Human KIR
Shown are comparisons of the 10 groups of chimpanzee KIR (designated by the prefix Pt) and 13 groups of human KIR. Shown in (A) is an
unrooted phylogenetic tree obtained by maximum parsimony analysis of the nucleotide sequence of the full-length coding regions of chimpanzee
and human KIR. Bootstrap values obtained from 1000 replicates for all branches are shown. Trees with similar topology were obtained by
the neighbor-joining method and also when using amino acid sequences (not shown). The scheme in (B) compares the sequences and domain
organization of the chimpanzee and human KIR. The three KIR lineages are separated by horizontal lines. Orthologous KIR are depicted on
the same line. The individual KIR domains: leader (L), D0, D1, D2, transmembrane (TM), and cytoplasmic tail (CYT) are indicated. The amino
acid at position 44 of D1 is indicated in single-letter code. The amino acid sequences of the ITIMs are depicted by a circle (VxYxxL), a square
(SxYxxL), a star (IxYxxL), and a triangle (TxYxxL). A dashed line indicates the presence in a gene of an unexpressed pseudoexon 3.
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Table 1. Variation of Chimpanzee and Human Lectin-like Receptors
CD94 NKG2A NKG2C
Protein length (aa)
Chimpanzee 179 233 231, 233
Human 179 233 231
Nucleotide differences
Chimpanzee versus human 2 7, 8 22±25
Chimpanzee versus chimpanzee 0 1 2±6
Human versus human 0 0 2
Amino acid differences
Chimpanzee versus human 1 4 14±17
Chimpanzee versus chimpanzee 0 0 2±5
Human versus human 0 0 2
This comparison is based on sequences derived from four common chimpanzees and six humans. NKG2A is represented by two alleles and
one allotype in the chimpanzee and by one allele in the human. NKG2C is represented by four alleles and four allotypes in the chimpanzee
and by two alleles and two allotypes in the human. The chimpanzee NKG2C pseudogene is not included in this analysis.
using RT±PCR amplification with oligonucleotide prim- trees constructed from the nucleotide sequences (Fig-
ers based upon sequences conserved in human KIR. ure 2A). The amino acid substitutions that distinguish
Clones were independently obtained from seven chim- the human and chimpanzee orthologs do not localize to
panzees and partial sequence analysis used to sort them any particular protein domains but are evenly distributed
into groups. Complete nucleotide sequences were de- throughout the sequence.
termined for 180 representative clones. These se- All 48 chimpanzees had the Pt-KIR2DL4 gene (Figure
quences formed ten groups of KIR that differ in se- 1), a ubiquitous distribution like that seen for KIR2DL4
quence by .10%. Within each group the sequences in the human population (Uhrberg et al., 1997). By con-
differed by ,2%. No chimpanzee KIR has identical se- trast, the distributions of the other conserved KIR are
quence to a human KIR. different in the two species: 85.4% of chimpanzees had
The ten groups of chimpanzee KIR comprise six with 2DL5 compared to 35% of humans (Vilches et al., 2000a),
three extracellular Ig domains (D01D11D2), two with 12% of chimpanzees had 2DS4 compared to 80% of
two Ig domains in the D01D2 configuration, and two humans (Uhrberg et al., 1997) (Figure 1). Like KIR2DL4,
with two Ig domains in the D11D2 configuration. Among Pt-KIR2DL4 has one immunoreceptor tyrosine-based in-
13 human KIR groups defined by the same criteria (Stef- hibitory motif (ITIM). But, whereas the ITIMs in KIR2DL4
fens et al., 1998), there are fewer 3Ig KIR (three com- corresponds to the amino-terminal one of the two ITIM
pared to six) and considerably more 2Ig KIR with the present in other inhibitory KIR, that in Pt-KIR2DL4 corre-
D11D2 configuration (eight compared to two). Both spe- sponds to the carboxy-terminal ITIM (Figure 2B).
cies, however, have two groups of 2Ig KIR with the The three main branches seen in the tree (Figure 2A)
D01D2 configuration. Of likely functional importance is correspond to three KIR lineages, each of which is repre-
the difference in the numbers of KIR having long or sented in chimpanzee and human KIR. The first lineage
short cytoplasmic tails: the former being associated with consists of the 2Ig KIR with the D01D2 configuration:
inhibitory function, the latter with activating function. 2DL4 and 2DL5. The second lineage consists only of
Chimpanzee KIR are predominantly long tailed (eight 3Ig KIR: two of the six groups of chimpanzee 3Ig KIR
compared to two with short tails), whereas in human (Pt-KIR3DL1/2 and Pt-KIR3DL3) and all three groups
KIR the representation is more even (seven long tailed
of human 3Ig KIR (KIR3DL1, KIR3DS1, and KIR3DL2).
and six short tailed).
Within this lineage are the human KIR with specificity
From the cDNA sequences and the known exon-intron
for HLA-B (KIR3DL1) (Litwin et al., 1994) and HLA-Aorganization of human KIR genes (Selvakumar et al.,
(KIR3DL2) (Dohring et al., 1996; Pende et al., 1996). Pt-1997; Wilson et al., 1997), a method of typing chimpan-
KIR3DL1/2 has z95% sequence similarity with bothzee KIR genes was devised and used to analyze a panel
KIR3DL1 and KIR3DL2, hence its name, and comprisesof 48 unrelated chimpanzees. Two KIR were present in
a patchwork of elements shared with either KIR3DL1 orall animals, while the other eight varied in frequency
KIR3DL2 plus additional, scattered substitutions. Likefrom 12%±85%. Thirty different KIR genotypes were de-
KIR3DL1, Pt-KIR3DL1/2 is polymorphic, with four closelytected, the most common having a frequency of 10.5%
related variants identified in the cDNA clones from seven(Figure 1). This diversity in chimpanzee KIR genotype
chimpanzees.surpasses that seen in a similarly sized human panel
Pt-KIR3DL3 is similar in sequence to Pt-KIR3DL1/2,(Uhrberg et al., 1997).
differing only in the D2 domain and the carboxyl-terminalPairwise comparison showed that three of the chim-
two-thirds of the D1 domain. There, Pt-KIR3DL3 has anpanzee KIR have high nucleotide sequence similarity
insertion of six nucleotides and seven nonsynonymous(.97%) with a human KIR: KIR2DL4, KIR2DL5, and
substitutions present in no other KIR. Segregation analy-KIR2DS4. These paired groups likely represent ortholo-
sis indicates that Pt-KIR3DL3 behaves as an allele ofgous genes, and each chimpanzee KIR has been given
the same gene as the Pt-KIR3DL1/2 variants (data notthe same name as its human counterpart, with addition
shown). In humans, KIR3DS1 and KIR3DL1 segregateof the prefix ªPt-º for Pan troglodytes: Pt-KIR2DL4, Pt-
as alleles of the same locus,while KIR3DL2 is clearly aKIR2DL5, and Pt-KIR2DS4. The transspecies relation-
ships of these three KIR are apparent from phylogenetic separate gene (Wilson et al., 2000). Thus, all these data
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Figure 3. Chimpanzee NK Cell Clones Express Diverse Combinations of Receptors and Differ in Inhibition by MHC Class I
The results of testing 21 chimpanzee NK cell clones for KIR expression, reactivity with anti-KIR antibodies, and MHC class I inhibitory specificity
are tabulated. A shaded box indicates a strong positive result, a half-shaded box indicates an equivocal result, and an unshaded box indicates
a negative result. ªntº indicates not tested and ªnaº indicates not applicable. KIR genotypes for the three chimpanzees from whom NK cell
clones were derived are also shown. As a negative control, cultures of feeder cells alone were typed.
are consistent with chimpanzees having one gene en- Moreover, analysis of Pt-KIR2DL6 and Pt-KIR2DS4,
which encode the two chimpanzee 2Ig KIR with D1 1 D2coding KIR of this lineage and humans having two. As
a lineage these, 3Ig KIR appear well represented: all configuration, reveals they too have pseudoexons 3 (Fig-
ure 2B).chimpanzees have Pt-KIR3DL1/2 (Figure 1), all humans
have KIR3DL2, and z90% have KIR3DL1 (Uhrberg et
al., 1997). NKC-Encoded Receptors for MHC Class I Are More
Conserved than KIR in Chimpanzees and HumansThe third KIR lineage is the most complicated, con-
sisting of all human and chimpanzee 2Ig KIR with D11D2 Complementary DNA clones encoding chimpanzee
CD94, NKG2A, and NKG2C were isolated from periph-configuration and four groups of chimpanzee 3Ig KIR.
This lineage contains all human KIR with HLA-C specific- eral blood or splenocytes using RT±PCR amplification
and oligonucleotide primers based upon published hu-ity; it also includes KIR2DS4 and Pt-KIR2DS4, the only
transspecies relationship between chimpanzee and hu- man sequences (Houchins et al., 1991; Chang et al.,
1995). Clones from three chimpanzees and six ethnicallyman KIR within the lineage. The remaining KIR exhibit
a stellate pattern of branching in the tree, with close diverse human donors were sequenced, allowing both
intraspecies and interspecies divergence to be as-relationships only seen between KIR of the same species
(Figure 2A). Thus, with the exception of KIR2DS4 and sessed.
Chimpanzee CD94, NKG2A, and NKG2C are closelyPt-KIR2DS4, there is extensive species-specific diver-
gence within this KIR lineage. related to their human homologs, exhibiting 99.6%,
99.0%, and 96.7% nucleotide sequence similarity withinGenes encoding human 2Ig KIR with the D11D2 con-
figuration all contain a nonexpressed pseudoexon re- the coding region, respectively (Table 1). No evidence
for genetic polymorphism of CD94 in either species waslated to exon 3 of 3Ig KIR (Wilson et al., 1997; Martin et
al., 2000; Vilches et al., 2000b). This property suggested obtained. However, several human and chimpanzee in-
dividuals expressed alternatively spliced CD94 formsthat this class of KIR evolved from genes encoding 3Ig
KIR, a model strongly supported by our finding that that differ in the inclusion of a glutamine codon after
codon 105 at the boundary between exons 4 and 5.chimpanzee 3Ig KIR are in the same lineage as human
and chimpanzee 2Ig KIR with the D11D2 configuration. No genetic polymorphism of NKG2A was detected in
Immunity
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Figure 4. Chimpanzee and Human CD94:NKG2A Have Similar MHC Class I Specificity
Shown are cytotoxicity assays for chimpanzee NK cell clone Cy1.3 against 721.221 transfectants expressing single chimpanzee (A and D) or
human (B and C) MHC class I allotypes. In (A)±(C), MHC class I allotypes either known or predicted to have leader peptides that bind HLA-E
and engage CD94:NKG2A are shown with black solid bars; other allotypes are shown with hatched bars. The vertical dashed line shows lysis
of untransfected 721.221 cells. (D) shows reversal of inhibition of Cy1.3 by the anti-CD94 antibody DX22. Target-cell lysis in the presence of
anti-CD94 (crosshatched bars) and the control anti-CD56 antibody, Leu19a (solid black bars) is compared.
humans, and in chimpanzees only two allelic variants with expression of Pt-KIR2DL6 (Figure 3). In cytolytic
assays, NK cell clones were tested for inhibition by indi-differing by one synonymous substitution were found.
However, the alternatively spliced NKG2B form of vidual chimpanzee and human MHC class I allotypes
expressed by 721.221 transfectants. Polymorphic pat-NKG2A (Houchins et al., 1991) was found in some indi-
viduals of both species. Chimpanzee and human NKG2C terns of inhibition were observed with MHC class I of
are more divergent than either NKG2A or CD94, and both species, and they differed from clone to clone.
polymorphism of this gene was found in both species The observed patterns of inhibition involve at least four
(Table 1). In addition, all chimpanzees transcribed an different inhibitory specificities, expressed singly or in
NKG2C-related pseudogene for which there is no evi- combination (Figure 3).
dence in humans. The pseudogene and the expressed The first inhibitory specificity corresponds to CD94:
NKG2C are equally diverged from human NKG2C, con- NKG2A. In humans this receptor recognizes complexes
sistent with the duplication leading to these two genes of HLA-E and peptides from MHC class I leaders that
being chimpanzee specific. have methionine at position 221 (Borrego et al., 1998;
Braud et al., 1998; Lee et al., 1998). Chimpanzee NK cell
clone Cy1.3 was inhibited by both chimpanzee (FigureChimpanzee NK Cells Express Diverse Receptor
4A) and human (Figures 4B and 4C) MHC class I allo-Combinations and Are Inhibited by Chimpanzee
types with a pattern correlating precisely with the pres-and Human MHC Class I
ence of methionine 221 in the leader sequence. Thus,Chimpanzee NK cell clones were derived from periph-
inhibition was seen with some HLA-A, B, and C anderal blood lymphocytes, and those that killed the MHC
Patr-A and C allotypes but with no Patr-B allotypes.class I±deficient human cell line 721.221 were selected
That anti-CD94 abrogated inhibition confirmed thefor further study. Of 30 NK cell clones analyzed for cyto-
involvement of CD94:NKG2A (Figure 4D). Moreover,toxicity, 21 were typed for expression of chimpanzee
NKG2A cDNA was isolated from clone Cy1.3 and its onlyKIR using an RT±PCR method based upon the cDNA
KIR was Pt-KIR2DL4 (Figure 3). In these experimentssequences. Chimpanzee NK cell clones expressed be-
(Figure 4), chimpanzee CD94:NKG2A interacts with hu-tween one and six KIR, with Pt-KIR2DL4 being the only
man HLA-E of the target cell. Such xenocompatibility isKIR expressed by all clones (Figure 3). Monoclonal anti-
consistent with the structural similarities of CD94 andbodies specific for human KIR were tested against chim-
NKG2A in the two species (Table 1) and also of theirpanzee NK cells and reactivity observed with DX9 spe-
MHC-E, which differ only at four residues (98.9% similar-cific for KIR3DL1 and with EB6 and HP3E4, both specific
ity) (Arnaiz-Villena et al., 1997).for KIR2DL1 and KIR2DS1. Comparison of the pattern
The second specificity is defined by a set of chimpan-of antibody binding with the RT±PCR typing of NK cell
zee (Figure 5A) and human (Figure 5B) MHC-B and Aclones showed that DX9 binding correlated with expres-
sion of Pt-KIR3DL1/2, whereas EB6 binding correlated allotypes that inhibited 18 of the 30 NK cell clones. For
Chimpanzee NK Cell Receptors
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Figure 5. Inhibition of DX91 Chimpanzee NK Cell Clones by Polymorphic MHC-B and A Determinants Does Not Correlate with Bw4 or Leader
Sequence Motifs
Shown are cytotoxicity assays in which the target cells are transfectants of 721.221 expressing single MHC class I allotypes. (A) and (B) show
cytolysis by the DX91 clone Cy1.27 of 721.221 transfectants expressing Patr class I allotypes (A) or HLA class I allotypes (B). Allotypes having
a Bw4 sequence motif are depicted with gray bars, allotypes having a Bw6 motif are shown with hatched bars, and allotypes having neither
motif are shown with black bars. The vertical dashed line shows lysis of untransfected 721.221 cells. Clone Cy1.27 did not express NKG2A
as determined by RT±PCR typing. In (C) and (D), MHC class I-mediated inhibition of a chimpanzee (C) and human DX91 NK cell clones (D) is
compared. Allotypes with a Bw4 sequence motif are indicated by gray bars, whereas allotypes with a Bw6 motif are indicated by hatched
bars. Patr-B*1601 has an unusual Bw4/Bw6 hybrid motif and is indicated by a checkered bar. The vertical dashed line shows lysis of
untransfected 721.221 cells.
clone Cy1.9, this ªMHC-B1Aº pattern was the only inhib- allotypes that have the S77, N80 motif (Figures 6A and
6B), a specificity identical to that of the human C1-itory specificity, whereas other clones were variably in-
hibited by MHC-C allotypes. MHC-B1A inhibition was specific receptors KIR2DL2, 2DL3, and 2DS2 (Colonna
et al., 1993; Wagtmann et al., 1995). Other NK cell clonesrestricted to NK cells that bound the DX9 antibody and
expressed the Pt-KIR3DL1/2 receptor (Figure 3). Con- exhibited the C1 specificity in combination with addi-
tional inhibitory specificities (Figure 3). All clones exhib-versely, all NK cells expressing the Pt-KIR3DL1/2 re-
ceptor bound the DX9 antibody and exhibited MHC-B1A iting the C1 specificity expressed Pt-KIR2DL6 and were
reactive with the monoclonal antibody EB6. These datainhibition. These results indicate that Pt-KIR3DL1/2 me-
diates MHC-B1A inhibition. indicate that Pt-KIR2DL6 has C1 specificity and an epi-
tope detected by the EB6 antibody.The extracellular region of Pt-KIR3DL1/2 is most simi-
lar to that of human KIR3DL1, consistent with its cross- Seven chimpanzee NK cell clones were inhibited
strongly by chimpanzee and human MHC-C allotypesreaction with the KIR3DL1-specific antibody DX9. How-
ever, the two KIR have different inhibitory specificity for having the N77, K80 motif, which in humans defines the
C2 inhibitory specificity (Colonna et al., 1993; MorettaMHC class I. Whereas KIR3DL1 is specific for MHC-B
allotypes having a Bw4 motif (Figure 5D) (Gumperz et et al., 1995). Four chimpanzee clones were inhibited only
by C2 allotypes (Figures 6C and 6D), while three othersal., 1995), Pt-KIR3DL1/2 has a MHC-B specificity that
does not include all MHC-B allotypes with a Bw4 motif were also inhibited by C1 allotypes. All NK cell clones
inhibited by C2 allotypes express Pt-KIR3DL4 and noand, conversely, includes some MHC-B allotypes with-
out a Bw4 motif (Figure 5C). Furthermore, Pt-KIR3DL1/2 other KIR correlates with this pattern of inhibition (Figure
3). In the RT±PCR assay, Pt-KIR3DL4 and Pt-KIR2DL4reacts with some MHC-A allotypes that KIR3DL1 does
not. Another difference between the two receptors is were the only inhibitory KIR expressed by clone Ea1.4,
which only exhibited the C2 inhibitory specificity (Fig-that addition of DX9 antibody abrogates inhibition
through KIR3DL1 but not through Pt-KIR3DL1/2 (data ures 6C and 6D). Furthermore, Pt-KIR3DL4 and Pt-
KIR2DL4 were the only inhibitory KIR represented in anot shown).
The third and fourth inhibitory specificities are for sequence analysis of 39 KIR cDNA clones from Ea1.4.
For human KIR2DL, the inhibitory MHC-C specificitiesMHC-C ligands. These were distinguishable from the
weaker MHC-C inhibition through the CD94:NKG2A re- correlate with substitution at position 44 of the D1 do-
main: lysine conferring C1 specificity, and methionine,ceptor. One pattern is illustrated by NK cell clone Cy1.28,
which was inhibited by chimpanzee and human MHC-C C2 specificity (Winter et al., 1998). That Pt-KIR2DL6 has
Immunity
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Figure 6. Chimpanzee NK Cell Clones Exhibit Two Different MHC-C Inhibitory Specificities
Shown are cytotoxicity assays in which the target cells are transfectants of 721.221 expressing single Patr-C (A and C) or HLA-C (B and D)
class I allotypes. MHC-C allotypes with serine at position 77 and asparagine at position 80 of the heavy chain are depicted by black bars;
those with asparagine 77 and lysine 80 are depicted by hatched bars. The vertical dashed line shows lysis of untransfected 721.221 cells.
Chimpanzee NK cell clone Cy1.28 (A and B) stained with monoclonal antibodies EB6 and HP3E4 (anti-KIR2DL1, -KIR2DS1) but not with DX9
(anti-KIR3DL1). Clone Ea1.4 (C and D) reacted with none of the three antibodies.
lysine 44 and Pt-KIR3DL4 has methionine 44 is therefore sampling of chimpanzee KIR cDNA, multiple animals
were studied using several pairs of amplification prim-consistent with this correlation. A point of difference is
that EB6 binds to human C2-specific receptors (Moretta ers. As chimpanzee KIR were defined and typing sys-
tems developed, cDNA clones were typed to identifyet al., 1995), whereas this antibody's binding was corre-
lated with the chimpanzee C1-specific receptor. This anti- clones different from the known KIR, which were there-
fore candidates for novel KIR. We also typed humangenic difference for an antibody selected for blocking
interaction with MHC (Moretta et al., 1990) correlates cDNA and genomic DNA samples using the typing sys-
tems developed for chimpanzee KIR to search for pre-with substitution at positions 33, 46, 48, 68, and 70 that
flank position 44 and are the positions at which Pt- viously undiscovered human KIR. In this manner, Pt-
KIR2DL5, discovered first in the chimpanzee, was shownKIR2DL6 is like human C2-specific receptors and differ-
ent from human C1-specific receptors. to have a human ortholog (Vilches et al., 2000a). Al-
though we cannot be certain that the defined KIR groups
completely represent chimpanzee KIR, they do accountDiscussion
for all the inhibitory reactions observed in assays of NK
activity, and they encompass the broad range of KIRChimpanzees, human's closest living relatives, have NK
cells that express diverse combinations of KIR and defined by the more extensive analysis of human KIR
(Steffens et al., 1998). As the methods for obtainingCD94:NKG2 receptors. Further evidence for an overall
similarity in ªdesignº of the NK cell recognition system chimpanzee KIR cDNA clones were based upon the
sequences of human KIR, their expected bias would bein chimpanzees and humans is their xenocompatibility:
the NK cell receptors of one species functionally recog- toward the isolation of the chimpanzee KIR that are most
like human KIR. If such ascertainment bias occurred, itnize MHC class I ligands of the other. However, within
this common organization we find a degree of difference would overestimate the similarities of human and chim-
panzee KIR, and thus could only enhance rather thanin the structure and function of chimpanzee and human
NK cell receptors that does not conform to the overall diminish the significance of the differences we report.
Overall, the CD94:NKG2 receptors are much more98.4% sequence similarity in the genomes of the two
species (Sibley et al., 1990). Instead, the extent and similar in chimpanzees and humans than are the KIR.
Orthologous genes encode the CD94 and NKG2A com-nature of the differences suggest they are the accumu-
lated consequence of independent selection by patho- ponents of the inhibitory MHC-E receptor, and they ap-
pear subject only to purifying selection. Within eachgens over the 5 million years since human and chimpan-
zee ancestors parted company (Horai et al., 1995). species, CD94 and NKG2A are monomorphic, and the
differences between the species are less than the ge-In performing this study we were concerned that some
chimpanzee KIR would elude discovery. To enhance nome average. Moreover, the functional specificity for
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complexes of MHC-E and peptides derived from the and B. Of the two human genes, KIR3DL1 is highly poly-
morphic and its product recognizes MHC-B (Litwin etleader sequence of other MHC class I heavy chains is
identical. The one nuance that could affect in vivo func- al., 1994), whereas KIR3DL2 is less polymorphic and its
product recognizes MHC-A (Dohring et al., 1996; Pendetion is due to the ligand rather than the receptor: human
MHC-B provides appropriate leader peptides whereas et al., 1996). Thus, in both structure and function the
chimpanzee and human KIR of this lineage are distin-chimpanzee MHC-B does not. By contrast with NKG2A,
the NKG2C polypeptide that associates with CD94 to guished.
A different situation is seen for the KIR with specificityform an activating receptor evolves faster than either
CD94 or NKG2A and may be subject to diversifying se- for MHC-C determinants and that are part of the lineage
containing both 2Ig and 3Ig KIR. Chimpanzee and hu-lection. NKG2C is polymorphic in chimpanzee and hu-
man populations, and its species divergence is greater man NK cells express inhibitory receptors with identical
specificity for the epitopes (C1 and C2) defined by alter-than the genome average. An additional species-spe-
cific difference is that the NKG2C gene has duplicated native substitutions at positions 77 and 80 of the MHC-C
heavy chain (Colonna et al., 1993). However, the chim-during chimpanzee evolution, a feature not seen in
humans. panzee and human KIR with identical MHC-C specificity
are structurally divergent and certainly not recognizableChimpanzees have a diversity in KIR genotype com-
parable to that described in humans (Uhrberg et al., as orthologs. Particularly striking, the C2 specificity is
carried by a chimpanzee 3Ig KIR (Pt-KIR3DL4) and a1997). This arises from haplotypic differences in gene
number and in allelic polymorphism. Common to the human 2Ig KIR (KIR2DL1). Study of in vitro mutants of
the human MHC-C-specific KIR has shown that allotypechimpanzee and human KIR families are three KIR lin-
eages that predate the last common ancestor. The most specificity is determined by the amino acid at position
44 of the D1 domain (Winter et al., 1998); consistent withconserved of these lineages is that encoding 2Ig KIR
with the D01D2 configuration (Selvakumar et al., 1997), this finding, the human and chimpanzee KIR that have
identical MHC-C specificity also have the identical resi-which consists in both species of orthologous 2DL4 and
2DL5. The only other KIR with chimpanzee and human due at this position.
Whereas the nonclassical class I genes of chimpan-orthologs is 2DS4, a part of the largest and most diverse
KIR lineage. This lineage contains all 2Ig KIR with the zees and humans are highly conserved (Arnaiz-Villena
et al., 1997), the classical class I genes have divergedD11D2 configuration and related chimpanzee 3Ig KIR.
Apart from 2DS4, there is no correspondence between to where no allotype is shared (Cooper et al., 1998). The
same trend toward species specificity is seen here forindividual chimpanzee and human KIR, but instead there
is extensive evidence for species-specific evolution, in- the NK cell receptors but is more striking because of
the diversity in the loci and in haplotypic gene number.cluding loss or gain in the expression of exon 3. The
remaining lineage contains only 3Ig KIR and is repre- Thus, receptors that interact with nonclassical MHC
class I ligands have been highly conserved during 5sented by one chimpanzee gene having divergent Pt-
KIR3DL1/2 and Pt-KIR3DL3 alleles and two human million years, while the KIR that interact with classical
MHC class I have diverged. The previous characteriza-genes, KIR3DL1 and KIR3DL2. All three of these KIR are
likely to have evolved from a common ancestor, but tion of KIR diversity within the human population pro-
vided evidence that balancing selection operates on thethey now have different structure and function. That Pt-
KIR3DL1/2 is a pastiche of sequence motifs present in KIR gene family (Uhrberg et al., 1997). However, these
data do not address the time frame over which the varia-the two human genes with additional, unique substitu-
tions illustrates the participation of gene duplication, tion can change. The comparison of chimpanzee and
human KIR described here demonstrates that changerecombination, and point mutation in the evolution of
KIR. can occur at rates comparable or greater to that seen
for classical MHC class I genes.Of the primate NK cell receptors with known MHC
class I specificity, the most highly conserved are those There are at least two possible mechanisms whereby
pathogen-mediated selection might act upon NK cellthat interact with nonclassical MHC class I molecules,
CD94:NKG2A with MHC-E and KIR2DL4 with MHC-G receptors. One mechanism involves pathogen selection
upon the cytotoxic T cell response, which selects for(Ponte et al., 1999; Rajagopalan and Long, 1999). Li-
gands for the other conserved KIR, 2DS4 and 2DL5, MHC variants that have advantage in presenting pep-
tides to T cells. A drawback to some of these MHCare not identified and in contrast to CD94:NKG2A and
KIR2DL4, their genes are present only in some haplotypes. class I variants could be poorer interaction with NK cell
receptors, which in turn could select for variant NK cellTheir distribution is nonetheless intriguing: KIR2DS4 is
conserved in the group A haplotypes, whereas KIR2DL5 receptors that interact better with them. In this indirect
mode of selection, the NK cell receptors evolve to ªcatchis characteristic of the group B haplotypes (Vilches et
al., 2000a). upº with innovations in MHC class I (Valiante et al.,
1997a). Possible situations where such selection wouldKIR with specificity for classical MHC class I mole-
cules are not conserved in chimpanzees and humans. operate are in the periods following epidemic disease
in which survival depended upon a CTL response toThe KIR lineage of 3Ig KIR contains all receptors re-
ported to have specificity for MHC-A and/or B (Litwin antigens presented by low-frequency MHC class I vari-
ants. Indeed, the many recombinant and regional MHC-Aet al., 1994; Dohring et al., 1996; Pende et al., 1996).
In the chimpanzee this lineage is represented by Pt- and B subtypes present in human populations are indic-
ative of such episodes of selection (Parham and Ohta,KIR3DL1/2, a polymorphic gene that encodes receptors
which recognize polymorphic determinants of MHC-A 1996). The modulated differences seen in the structure
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cycles at 948C for 15 s, 508C for 15 s, and 728C at 90 s; and a finaland MHC-A and B specificity of the human and chimpan-
extension at 728C for 10 min. The resulting PCR product was clonedzee 3Ig KIR seem compatible with this indirect, catch-
into the pCR4-TOPO vector and then sequenced as above.up form of selection.
The second type of selection acts directly upon the
Typing Chimpanzee NK Cell Receptors
NK cell response during the early phase of infection and Chimpanzee NK cell receptors were typed by PCR using sequence-
selects for variants that improve the ability of the innate specific primers (PCR-SSP). Primers had 39 ends positioned at
unique polymorphisms in each KIR and annealing temperatures be-immune response to impede or terminate infection be-
tween 588C and 628C. Primers specific for a 734 bp b-actin fragmentfore adaptive immunity comes into play. KIR variants
were included in all reactions as an internal control (Uhrberg et al.,selected in this direct way could have greater potential
1997). PCR conditions were as follows: initial denaturation, 958C forto reduce the effects of disease than those selected
3 min; then 5 cycles at: 958C for 20 s, 628C for 60 s, and 728C for
by ªcatch-upº selection and consequently may involve 45 s; then 30 cycles at 958C for 20 s, 608C for 40 s, and 728C for 90
more radical types of variation. This form of selection s; and then final extension at 728C for 10 min. PCR products were
analyzed on ethidium-bromide-stained 1.5% agarose gels. Tem-might explain the extensive structural differences in the
plates for the typing assay were cDNA and genomic DNA (Uhrbergchimpanzee and human KIR with identical MHC-C spec-
et al., 1997).ificity. Their differences are not consistent with neutral
evolution and the 98.4% sequence similarity in the chim-
Oligonucleotide Primers
panzee and human genomes (Sibley et al., 1990); neither This section describes the oligonucleotides used in typing. For pairs
can they be explained by selection for preservation of of oligonucleotides used in both DNA and in RNA typing, the size
MHC-C specificity. The remaining possibility is that of the product expected in the DNA typing assay is given first and
that for RNA typing is given second. Oligonucleotides used only forthese MHC-C receptors have additional, as yet un-
DNA or RNA typing are indicated by either DNA or RNA in parenthe-known, interactions that were selected by pathogens
ses. Pt-KIR3DL1/2: sense 59-AATCCACGTTCCCATCGG-39, anti-senseand in some way improved the NK cell response while
59-CGTGAGGGGTCCTGAGAG-39, 1755 bp, 300 bp; Pt-KIR3DL3:
preserving MHC-C specificity. sense 59-AATCCACGTTCCCATCGG-39, anti-sense 59-GCGCAAAG
In conclusion, this study of two closely related species TGTCCTCAAC-39, 1755 bp, 300 bp; Pt-KIR3DL4: sense 59-TAACGA
demonstrates that rapid evolution is a characteristic of CACTTTGCGCCA-39, anti-sense 59-GAGCCTACGTTCATGAGA-39,
1575 bp, 315 bp; Pt-KIR3DL5: sense 59-TCCCCCTATCAGTTGTCG-39,systems of NK cell receptors. Thus, the many and varied
anti-sense 59-ACCACTCGTAGGGAGATA-39, 2000 bp, 310 bp;differences seen in the NK cell receptors of humans
Pt-KIR3DL6: sense 59-CACGTTCTGATTGGGACG-39, anti-senseand mice no longer seem an anomaly, but what could
59-GCTGGTATCTGTTGGGGT-39, 850 bp, 260 bp; Pt-KIR2DL4: sense
reasonably be expected following an evolutionary sepa- 59-GCATGCTGTGATTAGGTA-39, anti-sense 59-AGTGATCCAACTG
ration that is about 20-fold longer than that of chimpan- TGCAC-39, 760 bp, 195 bp; Pt-KIR2DL5 (DNA): sense 59-GGCTAT
zees and humans (Kumar and Hedges, 1998). CATCCTCTTTAT-39, anti-sense 59-ACCTCCTGAGGGTCTTGA-39,
750 bp; Pt-KIR2DL5 (RNA): sense 59-GCAACCCCCTGGTGATCG-39,
anti-sense 59-ACCTCCTGAGGGTCTTGA-39, 590 bp; Pt-KIR2DL6:Experimental Procedures
sense 59-TCTGATTGGGACCTCAGC-39, anti-sense 59-GCCTCCGA
GAAGGGGGAT-39, 800 bp, 235 bp; Pt-KIR3DS2: sense 59-TAACGACells
CACTTTGCGCCA-39, anti-sense 59-GTCCTGCAGGGAGCCTAA-39,Peripheral blood was obtained from common chimpanzees (Pan
2000 bp, 325 bp; Pt-KIR2DS4 (DNA): sense 59-GTCAGCTCCCAGTtroglodytes) housed at Yerkes Regional Primate Center of Emory
GACCA-39, anti-sense 59-GGCTCTTGGTCCATTACG-39, 600 bp;University (Atlanta, GA) and the Laboratory for Experimental Medi-
Pt-KIR2DS4 (RNA): sense 59-GTCAGCTCCCAGTGACCA-39, anti-sensecine and Surgery in Primates (LEMSIP) (New York University Medical
59-GGCTCTTGGTCCATTACG-39, 520 bp; Pt-CD94 (RNA): senseCenter, Tuxedo, NY). PBMC were isolated on Ficoll-Hypaque gradi-
59-AGAAAACTTGGAACGAAAGTA-39, anti-sense 59-ATACGCTATGents. A spleen sample, obtained from the Yerkes Center, was macer-
CAGTTCTTTGG-39, 233 bp; Pt-NKG2A (RNA) sense 59-GAACAGGated with scalpels, strained through a 70 mm cell strainer, and the
AAATAACCTATGC-39, anti-sense 59-AAGCAGACCGGAGTTCTTT-39,splenocytes isolated on a Ficoll-Hypaque gradient. PBMC were
363 bp; Pt-NKG2C (RNA) sense 59-AGAAGTGAGTCTGGCCCtransformed with Epstein Barr virus (Lawlor et al., 1990).
AGG-39, anti-sense 59-CCAGGAAAGGAATAAGAACTATG -39, 266 bp.
Nucleotide Sequence Analysis
Phylogenetic TreesChimpanzee KIR
Phylogenetic trees were built with the PAUP program (Swofford,RNA was extracted from chimpanzee PBMC and reverse transcribed
1999) using maximum parsimony (Fitch, 1977) and neighbor-joining(Uhrberg et al., 1997). KIR sequences were amplified using the sense
methods (Saitou and Nei, 1987). Confidence in each tree branchprimer 2IGF and anti-sense primer NKR (Valiante et al., 1997b). PCR
was estimated using the bootstrap technique (Felsenstein, 1985).conditions were as follows: initial denaturation for 1 min at 948C;
then 25±30 cycles at 948C for 15 s, 508C for 15 s, and 728C at 90 s;
NK Cell Clones and Cytolytic Assaysand a final extension at 728C for 10 min. Following purification with
Chimpanzee NK cell clones were obtained from CD32CD16/561the QIAquick kit (Qiagen, Chatsworth, CA), the PCR product was
PBMC or splenocytes by methods like those used for human NKcloned into either the pBluescript II SK1 (Stratagene, La Jolla, CA) or
cells (Valiante et al., 1997b). Cell killing assays were performed usingthe pCR2.1-TOPO (Invitrogen, Carlsbad, CA) vector and sequenced
NK cell clones as effectors and the 721.221 cell line and its deriva-using dye-terminator automated sequencing (Applied Biosystems,
tives expressing single human or chimpanzee MHC class I allotypesFoster City, CA).
as targets (Valiante et al., 1997b). All clones lysed untransfectedHuman and Chimpanzee CD94, NKG2A, and NKG2C
721.221 cells at levels greater than 30% specific lysis. In blockingRNA was extracted and reverse transcribed from chimpanzee
experiments antibodies were used at 10 mg/ml.PBMC, splenocytes, and cloned NK cells and from the PBMC of
six ethnically diverse humans. cDNA was amplified using primers:
CD94-PCRF, 59-CCTTCTCTACTTCGCTCTTG-39, and CD94-PCRR, Monoclonal Antibodies
Leu4 (anti-CD3) and B159 (anti-CD56) were purchased from Becton59-TAATGTTGGGTCTTTACTCTC-39 (CD94); NKG2A-PCRF, 59-CTG
GGGACAGAAGAGTACCGT-39, and NKG2-PCRR, 59-GCCCGACAC Dickinson-PharMingen and 3G8 (anti-CD16) from Caltag (Burlin-
game, CA). Anti-KIR antibodies were DX9-PE (anti-KIR3DL1), DX22-AAATGCTAGGAT-39 (NKG2A); and NKG2C-PCRF, 59-AGCACAG
TCCTTCACATCACA-39, and NKG2-PCRR (NKG2C). PCR conditions FITC (anti-CD94), DX27-PE (anti-KIR2DL2/3 and -KIR2DS2), EB6-
PE (anti-KIR2DL1 and -KIR2DS1) (Coulter-Immunotech, Miami, FL),were as follows: initial denaturation for 1 min at 948C; then 25±30
Chimpanzee NK Cell Receptors
697
GL183-PE (anti-KIR2DL2/3 and -KIR2DS2) (Coulter-Immunotech), Fitch, W.M. (1977). On the problem of discovering the most parsimo-
nious tree. Am. Nat. 111, 223±257.and HP3E4-FITC (broad anti-KIR2D) (a gift of Prof. M. LoÂ pez-Botet).
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